Symbol:
Aldh18a1
Name:
aldehyde dehydrogenase 18 family, member A1
RGD ID:
1311431
Description:
Predicted to enable glutamate 5-kinase activity; glutamate-5-semialdehyde dehydrogenase activity; and identical protein binding activity. Involved in response to temperature stimulus. Located in mitochondrial membrane. Human ortholog(s) of this gene implicated in cataract; cutis laxa (multiple); enterocele; and hereditary spastic paraplegia (multiple). Orthologous to human ALDH18A1 (aldehyde dehydrogenase 18 family member A1); PARTICIPATES IN arginine and proline metabolic pathway; INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
delta-1-pyrroline-5-carboxylate synthase; LOC108348083; LOC361755; Pycs; pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 249,325,082 - 249,357,383 (-) NCBI GRCr8 mRatBN7.2 1 239,375,657 - 239,407,956 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 239,375,669 - 239,407,890 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 247,511,391 - 247,543,700 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 254,215,141 - 254,247,493 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 246,868,177 - 246,900,530 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 259,641,673 - 259,674,521 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 259,641,676 - 259,674,425 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 259,057,402 - 259,089,642 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 267,085,392 - 267,117,725 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 1 266,505,493 - 266,537,820 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 245,685,979 - 245,718,198 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 245,796,065 - 245,825,127 (-) NCBI Celera 1 235,221,086 - 235,253,280 (-) NCBI Celera Cytogenetic Map 1 q54 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Aldh18a1 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALDH18A1 mRNA] CTD PMID:31150632 Aldh18a1 Rat 1,1-dichloroethene increases expression ISO Aldh18a1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of ALDH18A1 mRNA CTD PMID:26682919 Aldh18a1 Rat 17alpha-ethynylestradiol increases expression ISO Aldh18a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ALDH18A1 mRNA CTD PMID:12072388 Aldh18a1 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ALDH18A1 mRNA CTD PMID:32145629 Aldh18a1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Aldh18a1 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Aldh18a1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ALDH18A1 mRNA CTD PMID:22298810 Aldh18a1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Aldh18a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ALDH18A1 mRNA CTD PMID:21570461 Aldh18a1 Rat 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of ALDH18A1 protein CTD PMID:32044396 Aldh18a1 Rat 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ALDH18A1 mRNA CTD PMID:30723492 Aldh18a1 Rat 4-hydroxyphenyl retinamide decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Fenretinide results in decreased expression of ALDH18A1 mRNA CTD PMID:28973697 Aldh18a1 Rat 4-hydroxyphenyl retinamide increases expression ISO Aldh18a1 (Mus musculus) 6480464 Fenretinide results in increased expression of ALDH18A1 mRNA CTD PMID:28973697 Aldh18a1 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ALDH18A1 mRNA CTD PMID:28959563 Aldh18a1 Rat acrylamide decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of ALDH18A1 mRNA CTD PMID:32763439 Aldh18a1 Rat actinomycin D multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ALDH18A1 protein CTD PMID:38460933 Aldh18a1 Rat adefovir pivoxil decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 adefovir dipivoxil results in decreased expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat aflatoxin B1 decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of ALDH18A1 mRNA CTD PMID:19770486 Aldh18a1 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ALDH18A1 mRNA CTD PMID:23630614 and PMID:25378103 Aldh18a1 Rat aldrin increases expression ISO Aldh18a1 (Mus musculus) 6480464 Aldrin results in increased expression of ALDH18A1 mRNA CTD PMID:18579281 Aldh18a1 Rat all-trans-retinoic acid decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ALDH18A1 mRNA CTD PMID:33167477 Aldh18a1 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ALDH18A1 mRNA CTD PMID:35163327 Aldh18a1 Rat alpha-Zearalanol increases expression EXP 6480464 Zeranol results in increased expression of ALDH18A1 mRNA CTD PMID:35163327 Aldh18a1 Rat aminophylline increases expression ISO Aldh18a1 (Mus musculus) 6480464 Aminophylline results in increased expression of ALDH18A1 mRNA CTD PMID:29901742 Aldh18a1 Rat aristolochic acid A decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ALDH18A1 mRNA CTD PMID:33212167 Aldh18a1 Rat azathioprine decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of ALDH18A1 mRNA CTD PMID:22623647 Aldh18a1 Rat benzo[a]pyrene decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ALDH18A1 mRNA CTD PMID:19770486 Aldh18a1 Rat benzo[a]pyrene increases methylation ISO ALDH18A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ALDH18A1 promoter CTD PMID:27901495 Aldh18a1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALDH18A1 mRNA CTD PMID:25181051 and PMID:33296240 Aldh18a1 Rat bisphenol A decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ALDH18A1 protein CTD PMID:34186270 and PMID:37567409 Aldh18a1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALDH18A1 mRNA CTD PMID:30816183 more ... Aldh18a1 Rat bisphenol A affects expression ISO ALDH18A1 (Homo sapiens) 6480464 bisphenol A affects the expression of ALDH18A1 mRNA CTD PMID:30903817 Aldh18a1 Rat bisphenol AF increases expression ISO ALDH18A1 (Homo sapiens) 6480464 bisphenol AF results in increased expression of ALDH18A1 protein CTD PMID:34186270 Aldh18a1 Rat bisphenol F increases expression ISO ALDH18A1 (Homo sapiens) 6480464 bisphenol F results in increased expression of ALDH18A1 protein CTD PMID:34186270 Aldh18a1 Rat bortezomib decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Bortezomib results in decreased expression of ALDH18A1 mRNA CTD PMID:20977926 Aldh18a1 Rat cadmium dichloride decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat caffeine decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Caffeine results in decreased expression of ALDH18A1 mRNA CTD PMID:11793227 Aldh18a1 Rat caffeine increases phosphorylation ISO ALDH18A1 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of ALDH18A1 protein CTD PMID:35688186 Aldh18a1 Rat carbon nanotube increases expression ISO Aldh18a1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Aldh18a1 Rat chloroacetaldehyde affects expression ISO ALDH18A1 (Homo sapiens) 6480464 chloroacetaldehyde affects the expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat chlorpyrifos decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of ALDH18A1 mRNA CTD PMID:37019170 Aldh18a1 Rat choline multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH18A1 mRNA CTD PMID:20938992 Aldh18a1 Rat cidofovir anhydrous affects expression ISO ALDH18A1 (Homo sapiens) 6480464 Cidofovir affects the expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat cisplatin decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ALDH18A1 mRNA CTD PMID:24280081 and PMID:25596134 Aldh18a1 Rat cisplatin decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Cisplatin results in decreased expression of ALDH18A1 mRNA CTD PMID:24280081 Aldh18a1 Rat clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDH18A1 mRNA CTD PMID:17602206 Aldh18a1 Rat cobalt dichloride decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ALDH18A1 mRNA CTD PMID:19320972 Aldh18a1 Rat copper atom multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ALDH18A1 mRNA CTD PMID:20971185 Aldh18a1 Rat copper(0) multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ALDH18A1 mRNA CTD PMID:20971185 Aldh18a1 Rat copper(II) sulfate decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ALDH18A1 mRNA CTD PMID:19549813 Aldh18a1 Rat corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of ALDH18A1 mRNA CTD PMID:15755911 Aldh18a1 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ALDH18A1 mRNA CTD PMID:26577399 Aldh18a1 Rat Cuprizon decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Cuprizone results in decreased expression of ALDH18A1 protein CTD PMID:34122009 Aldh18a1 Rat cyclosporin A increases expression ISO Aldh18a1 (Mus musculus) 6480464 Cyclosporine results in increased expression of ALDH18A1 mRNA CTD PMID:19770486 Aldh18a1 Rat cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat cyclosporin A decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ALDH18A1 mRNA CTD PMID:20106945 more ... Aldh18a1 Rat dexamethasone decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Dexamethasone results in decreased expression of ALDH18A1 mRNA CTD PMID:22733784 Aldh18a1 Rat Dibutyl phosphate affects expression ISO ALDH18A1 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of ALDH18A1 mRNA CTD PMID:37042841 Aldh18a1 Rat diclofenac increases expression ISO Aldh18a1 (Mus musculus) 6480464 Diclofenac results in increased expression of ALDH18A1 mRNA CTD PMID:26934552 Aldh18a1 Rat diclofenac decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Diclofenac results in decreased expression of ALDH18A1 mRNA CTD PMID:35537566 Aldh18a1 Rat dioxygen increases expression ISO ALDH18A1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat enzyme inhibitor multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ALDH18A1 protein CTD PMID:23301498 Aldh18a1 Rat ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ALDH18A1 mRNA CTD PMID:31078653 Aldh18a1 Rat ethyl methanesulfonate decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of ALDH18A1 mRNA CTD PMID:23649840 Aldh18a1 Rat folic acid multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH18A1 mRNA CTD PMID:20938992 Aldh18a1 Rat folic acid decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Folic Acid results in decreased expression of ALDH18A1 mRNA CTD PMID:25629700 Aldh18a1 Rat FR900359 increases phosphorylation ISO ALDH18A1 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of ALDH18A1 protein CTD PMID:37730182 Aldh18a1 Rat furan increases expression EXP 6480464 furan results in increased expression of ALDH18A1 mRNA CTD PMID:25539665 Aldh18a1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ALDH18A1 mRNA CTD PMID:22061828 Aldh18a1 Rat haloperidol decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Haloperidol results in decreased expression of ALDH18A1 protein CTD PMID:34122009 Aldh18a1 Rat hydralazine multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH18A1 mRNA CTD PMID:17183730 Aldh18a1 Rat indometacin increases expression EXP 6480464 Indomethacin results in increased expression of ALDH18A1 mRNA CTD PMID:36868495 Aldh18a1 Rat irinotecan decreases expression EXP 6480464 Irinotecan results in decreased expression of ALDH18A1 mRNA CTD PMID:30012503 Aldh18a1 Rat ivermectin decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ALDH18A1 protein CTD PMID:32959892 Aldh18a1 Rat ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ALDH18A1 mRNA CTD PMID:20080153 Aldh18a1 Rat L-methionine multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALDH18A1 mRNA CTD PMID:20938992 Aldh18a1 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ALDH18A1 mRNA CTD PMID:28801915 Aldh18a1 Rat menadione affects expression ISO ALDH18A1 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of ALDH18A1 mRNA CTD PMID:20044591 Aldh18a1 Rat mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of ALDH18A1 mRNA CTD PMID:16507785 Aldh18a1 Rat metformin increases expression EXP 6480464 Metformin results in increased expression of ALDH18A1 mRNA CTD PMID:25596134 Aldh18a1 Rat methidathion increases expression ISO Aldh18a1 (Mus musculus) 6480464 methidathion results in increased expression of ALDH18A1 mRNA CTD PMID:34813904 Aldh18a1 Rat methyl methanesulfonate decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of ALDH18A1 mRNA CTD PMID:23649840 Aldh18a1 Rat N(4)-hydroxycytidine increases expression ISO Aldh18a1 (Mus musculus) 6480464 N(4)-hydroxycytidine results in increased expression of ALDH18A1 mRNA CTD PMID:37748715 Aldh18a1 Rat N-methyl-4-phenylpyridinium increases expression ISO Aldh18a1 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ALDH18A1 protein CTD PMID:26558463 Aldh18a1 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ALDH18A1 mRNA CTD PMID:28801915 Aldh18a1 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDH18A1 mRNA CTD PMID:17602206 Aldh18a1 Rat N-nitrosodiethylamine increases expression ISO Aldh18a1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of ALDH18A1 mRNA CTD PMID:24535843 Aldh18a1 Rat N-nitrosodimethylamine decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Dimethylnitrosamine results in decreased expression of ALDH18A1 mRNA CTD PMID:17547211 Aldh18a1 Rat Nutlin-3 multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ALDH18A1 protein CTD PMID:38460933 Aldh18a1 Rat ozone multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALDH18A1 mRNA CTD PMID:34911549 Aldh18a1 Rat paracetamol decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ALDH18A1 mRNA CTD PMID:11793227 and PMID:25704631 Aldh18a1 Rat PCB138 multiple interactions ISO Aldh18a1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Aldh18a1 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ALDH18A1 mRNA CTD PMID:35163327 Aldh18a1 Rat phenobarbital affects expression ISO Aldh18a1 (Mus musculus) 6480464 Phenobarbital affects the expression of ALDH18A1 mRNA CTD PMID:23091169 Aldh18a1 Rat phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ALDH18A1 mRNA CTD PMID:18158353 Aldh18a1 Rat pirinixic acid decreases expression ISO Aldh18a1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of ALDH18A1 mRNA CTD PMID:17426115 Aldh18a1 Rat resveratrol increases expression ISO Aldh18a1 (Mus musculus) 6480464 resveratrol results in increased expression of ALDH18A1 protein CTD PMID:25505154 Aldh18a1 Rat SB 431542 multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ALDH18A1 protein CTD PMID:37664457 Aldh18a1 Rat sodium arsenate decreases expression ISO Aldh18a1 (Mus musculus) 6480464 sodium arsenate results in decreased expression of ALDH18A1 mRNA CTD PMID:21795629 Aldh18a1 Rat sodium arsenite decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ALDH18A1 mRNA CTD PMID:38568856 Aldh18a1 Rat sodium arsenite increases expression ISO ALDH18A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ALDH18A1 mRNA CTD PMID:34032870 Aldh18a1 Rat sunitinib decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ALDH18A1 mRNA CTD PMID:31533062 Aldh18a1 Rat testosterone decreases expression ISO Aldh18a1 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of ALDH18A1 mRNA CTD PMID:33848595 Aldh18a1 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALDH18A1 mRNA] CTD PMID:31150632 Aldh18a1 Rat tetrachloromethane increases expression ISO Aldh18a1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ALDH18A1 mRNA CTD PMID:31919559 Aldh18a1 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ALDH18A1 mRNA CTD PMID:30723492 and PMID:31150632 Aldh18a1 Rat thapsigargin increases expression ISO Aldh18a1 (Mus musculus) 6480464 Thapsigargin results in increased expression of ALDH18A1 protein CTD PMID:24648495 Aldh18a1 Rat thioacetamide decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Thioacetamide results in decreased expression of ALDH18A1 mRNA CTD PMID:11793227 Aldh18a1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ALDH18A1 mRNA CTD PMID:23411599 Aldh18a1 Rat thiram decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Thiram results in decreased expression of ALDH18A1 mRNA CTD PMID:38568856 Aldh18a1 Rat titanium dioxide decreases methylation ISO Aldh18a1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ALDH18A1 gene CTD PMID:35295148 Aldh18a1 Rat tolcapone affects binding EXP 6480464 tolcapone binds to ALDH18A1 protein CTD PMID:19783845 Aldh18a1 Rat tributylstannane increases expression ISO Aldh18a1 (Mus musculus) 6480464 tributyltin results in increased expression of ALDH18A1 mRNA CTD PMID:31939706 Aldh18a1 Rat triphenyl phosphate affects expression ISO ALDH18A1 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of ALDH18A1 mRNA CTD PMID:37042841 Aldh18a1 Rat triptonide decreases expression ISO Aldh18a1 (Mus musculus) 6480464 triptonide results in decreased expression of ALDH18A1 mRNA CTD PMID:33045310 Aldh18a1 Rat tris(2-butoxyethyl) phosphate affects expression ISO ALDH18A1 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of ALDH18A1 mRNA CTD PMID:29024780 Aldh18a1 Rat trovafloxacin decreases expression ISO Aldh18a1 (Mus musculus) 6480464 trovafloxacin results in decreased expression of ALDH18A1 mRNA CTD PMID:35537566 Aldh18a1 Rat urethane decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 Urethane results in decreased expression of ALDH18A1 mRNA CTD PMID:28818685 Aldh18a1 Rat valproic acid multiple interactions ISO ALDH18A1 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH18A1 mRNA CTD PMID:17183730 Aldh18a1 Rat zoledronic acid decreases expression ISO ALDH18A1 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of ALDH18A1 mRNA CTD PMID:25596134
Imported Annotations - KEGG (archival)
(+)-schisandrin B (EXP) 1,1-dichloroethene (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-amino-14,16-dimethyloctadecan-3-ol (ISO) 4,4'-diaminodiphenylmethane (EXP) 4-hydroxyphenyl retinamide (ISO) acrylamide (EXP,ISO) actinomycin D (ISO) adefovir pivoxil (ISO) aflatoxin B1 (EXP,ISO) aldrin (ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) aminophylline (ISO) aristolochic acid A (ISO) azathioprine (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) bisphenol F (ISO) bortezomib (ISO) cadmium dichloride (ISO) caffeine (ISO) carbon nanotube (ISO) chloroacetaldehyde (ISO) chlorpyrifos (ISO) choline (ISO) cidofovir anhydrous (ISO) cisplatin (ISO) clofibric acid (EXP) cobalt dichloride (ISO) copper atom (ISO) copper(0) (ISO) copper(II) sulfate (ISO) corticosterone (EXP) Cuprizon (EXP,ISO) cyclosporin A (EXP,ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) diclofenac (ISO) dioxygen (ISO) enzyme inhibitor (ISO) ethanol (EXP) ethyl methanesulfonate (ISO) folic acid (ISO) FR900359 (ISO) furan (EXP) gentamycin (EXP) haloperidol (ISO) hydralazine (ISO) indometacin (EXP) irinotecan (EXP) ivermectin (ISO) ketamine (EXP) L-methionine (ISO) manganese(II) chloride (EXP) menadione (ISO) mercury dichloride (EXP) metformin (EXP) methidathion (ISO) methyl methanesulfonate (ISO) N(4)-hydroxycytidine (ISO) N-methyl-4-phenylpyridinium (EXP,ISO) N-nitrosodiethylamine (EXP,ISO) N-nitrosodimethylamine (ISO) Nutlin-3 (ISO) ozone (ISO) paracetamol (ISO) PCB138 (ISO) perfluorooctanoic acid (EXP) phenobarbital (ISO) phenylephrine (EXP) pirinixic acid (ISO) resveratrol (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sunitinib (ISO) testosterone (ISO) tetrachloromethane (EXP,ISO) thapsigargin (ISO) thioacetamide (EXP,ISO) thiram (ISO) titanium dioxide (ISO) tolcapone (EXP) tributylstannane (ISO) triphenyl phosphate (ISO) triptonide (ISO) tris(2-butoxyethyl) phosphate (ISO) trovafloxacin (ISO) urethane (ISO) valproic acid (ISO) zoledronic acid (ISO)
1.
A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome.
Bicknell LS, etal., Eur J Hum Genet. 2008 Oct;16(10):1176-86. doi: 10.1038/ejhg.2008.91. Epub 2008 May 14.
2.
Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
Coutelier M, etal., Brain. 2015 Aug;138(Pt 8):2191-205. doi: 10.1093/brain/awv143. Epub 2015 May 29.
3.
Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1.
Fischer B, etal., Mol Genet Metab. 2014 Aug;112(4):310-6. doi: 10.1016/j.ymgme.2014.05.003. Epub 2014 May 21.
4.
Recurrent De Novo Mutations Affecting Residue Arg138 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis Laxa.
Fischer-Zirnsak B, etal., Am J Hum Genet. 2015 Sep 3;97(3):483-92. doi: 10.1016/j.ajhg.2015.08.001. Epub 2015 Aug 27.
5.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
7.
Loss of ALDH18A1 function is associated with a cellular lipid droplet phenotype suggesting a link between autosomal recessive cutis laxa type 3A and Warburg Micro syndrome.
Handley MT, etal., Mol Genet Genomic Med. 2014 Jul;2(4):319-25. doi: 10.1002/mgg3.70. Epub 2014 Mar 11.
8.
Factors influencing pyrroline 5-carboxylate synthesis from glutamate by rat intestinal mucosa mitochondria.
Henslee JG, etal., Arch Biochem Biophys. 1983 Oct 15;226(2):693-703.
9.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
10.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
11.
ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
Panza E, etal., Brain. 2016 Jan;139(Pt 1):e3. doi: 10.1093/brain/awv247. Epub 2015 Aug 21.
12.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
13.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
14.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
15.
Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. Subcellular localization and temperature stability.
Wakabayashi Y, etal., J Biol Chem. 1983 Mar 25;258(6):3873-82.
Aldh18a1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 249,325,082 - 249,357,383 (-) NCBI GRCr8 mRatBN7.2 1 239,375,657 - 239,407,956 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 239,375,669 - 239,407,890 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 247,511,391 - 247,543,700 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 254,215,141 - 254,247,493 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 246,868,177 - 246,900,530 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 259,641,673 - 259,674,521 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 259,641,676 - 259,674,425 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 259,057,402 - 259,089,642 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 267,085,392 - 267,117,725 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 1 266,505,493 - 266,537,820 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 245,685,979 - 245,718,198 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 245,796,065 - 245,825,127 (-) NCBI Celera 1 235,221,086 - 235,253,280 (-) NCBI Celera Cytogenetic Map 1 q54 NCBI
ALDH18A1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 95,605,941 - 95,656,711 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 10 95,605,941 - 95,656,711 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 10 97,365,698 - 97,416,468 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 97,355,676 - 97,406,557 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 10 97,355,691 - 97,406,372 NCBI Celera 10 91,106,883 - 91,157,764 (-) NCBI Celera Cytogenetic Map 10 q24.1 NCBI HuRef 10 90,993,396 - 91,044,247 (-) NCBI HuRef CHM1_1 10 97,647,547 - 97,698,414 (-) NCBI CHM1_1 T2T-CHM13v2.0 10 96,485,079 - 96,535,811 (-) NCBI T2T-CHM13v2.0
Aldh18a1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 19 40,538,701 - 40,576,907 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 19 40,538,701 - 40,576,907 (-) Ensembl GRCm39 Ensembl GRCm38 19 40,550,257 - 40,588,463 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 19 40,550,257 - 40,588,463 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 19 40,624,747 - 40,662,953 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 19 40,603,568 - 40,641,680 (-) NCBI MGSCv36 mm8 Celera 19 41,354,703 - 41,390,340 (-) NCBI Celera Cytogenetic Map 19 C3 NCBI cM Map 19 34.25 NCBI
Aldh18a1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955507 1,892,061 - 1,946,703 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955507 1,892,087 - 1,946,526 (-) NCBI ChiLan1.0 ChiLan1.0
ALDH18A1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 8 107,509,648 - 107,560,640 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 10 107,514,963 - 107,565,958 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 10 92,216,639 - 92,267,525 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 10 95,723,099 - 95,774,095 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 10 95,723,099 - 95,774,095 (-) Ensembl panpan1.1 panPan2
ALDH18A1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 28 9,101,578 - 9,148,063 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 28 9,102,282 - 9,147,992 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 28 9,277,306 - 9,324,003 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 28 9,363,581 - 9,410,371 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 28 9,363,590 - 9,410,427 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 28 9,080,159 - 9,126,835 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 28 9,138,798 - 9,185,591 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 28 9,282,780 - 9,329,594 (-) NCBI UU_Cfam_GSD_1.0
LOC101975532 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 37,740,140 - 37,762,024 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936636 3,760,326 - 3,801,073 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936636 3,779,259 - 3,800,846 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ALDH18A1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 107,170,689 - 107,221,215 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 107,174,062 - 107,221,373 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 116,807,918 - 116,855,192 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ALDH18A1 (Chlorocebus sabaeus - green monkey)
Aldh18a1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 445 Count of miRNA genes: 216 Interacting mature miRNAs: 257 Transcripts: ENSRNOT00000020940 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 1357335 Bw39 Body weight QTL 39 3.3 body mass (VT:0001259) body weight (CMO:0000012) 1 197814409 242814409 Rat 631690 Scl5 Serum cholesterol level QTL 5 2.1 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 1 236125214 260522016 Rat 2302375 Bw83 Body weight QTL 83 4.87 0.0002 body mass (VT:0001259) body weight (CMO:0000012) 1 197697768 242697768 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2293674 Bss39 Bone structure and strength QTL 39 7.1 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 1 201554356 246554356 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 61327 Eae7 Experimental allergic encephalomyelitis QTL 7 5.6 body mass (VT:0001259) change in body weight (CMO:0002045) 1 216255568 260522016 Rat 1600392 Bw123 Body weight QTL 123 0.001 body mass (VT:0001259) body weight (CMO:0000012) 1 223201027 260522016 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 631837 Niddm35 Non-insulin dependent diabetes mellitus QTL 35 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 238699859 259647894 Rat 1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 2.2 uterus morphology trait (VT:0001120) percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759) 1 206081677 251081677 Rat 631836 Stl31 Serum triglyceride level QTL 31 4.64 5e-06 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 1 237147813 260522016 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 2293694 Bss38 Bone structure and strength QTL 38 7.05 0.0001 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 1 201554356 246554356 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 1300108 Rf8 Renal function QTL 8 3.75 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 1 228581588 259647894 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 body mass (VT:0001259) body weight (CMO:0000012) 1 224054293 260122809 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631215 Stl8 Serum triglyceride level QTL 8 9.27 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 1 225126575 260522016 Rat 631843 Bw116 Body weight QTL 116 4.1 0.016 abdominal adipose amount (VT:1000220) abdominal fat pad weight (CMO:0000088) 1 224054293 260122809 Rat 2300175 Bmd40 Bone mineral density QTL 40 15.4 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 1 201554356 246554356 Rat 731175 Uae20 Urinary albumin excretion QTL 20 3.5 0.0018 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 221264111 259647894 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 724538 Kidm1 Kidney mass QTL 1 3.2 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 213707201 252085212 Rat 2293655 Bss36 Bone structure and strength QTL 36 10.66 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 201554356 246554356 Rat 1298084 Thym4 Thymus enlargement QTL 4 10.68 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 197814409 242814409 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 body mass (VT:0001259) body weight (CMO:0000012) 1 224569538 260122809 Rat 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 body mass (VT:0001259) body weight (CMO:0000012) 1 213843987 258843987 Rat 1358890 Bp259 Blood pressure QTL 259 3.06 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 210702053 260522016 Rat 724533 Rf51 Renal function QTL 51 5.3 0.0002 kidney plasma flow trait (VT:0005524) renal plasma flow (CMO:0001914) 1 218753816 256448513 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 1358292 Cm37 Cardiac mass QTL 37 6.2 8e-07 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 1 196248093 241248093 Rat 61376 Bp42 Blood pressure QTL 42 23.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 197814409 242814409 Rat 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 199050459 259647894 Rat 1549910 Bw54 Body weight QTL 54 0.05 body mass (VT:0001259) body weight (CMO:0000012) 1 214647894 259647894 Rat 70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 3.79 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 214647894 259647894 Rat 1357399 Bw45 Body weight QTL 45 3.05 body mass (VT:0001259) body mass index (BMI) (CMO:0000105) 1 206329708 251329708 Rat 724552 Glom2 Glomerulus QTL 2 3.3 0.0001 kidney glomerulus morphology trait (VT:0005325) count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) 1 222363780 260522016 Rat 2316896 Gluco57 Glucose level QTL 57 7.2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 228985440 245907899 Rat 1357404 Bw42 Body weight QTL 42 4.49 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 1 206329708 251329708 Rat 10053715 Scort24 Serum corticosterone level QTL 24 2.13 0.0088 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 1 221414816 260522016 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 1358916 Kidm22 Kidney mass QTL 22 3.32 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 210702053 240947965 Rat 634321 Hc1 Hypercalciuria QTL 1 2.91 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 178810256 240830002 Rat 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 11 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 218753689 245907899 Rat 10059587 Bw173 Body weight QTL 173 3.23 0.025 body mass (VT:0001259) body weight (CMO:0000012) 1 202069611 247069611 Rat 2292216 Bw80 Body weight QTL 80 3.23 0.0019 body mass (VT:0001259) body weight (CMO:0000012) 1 213533809 243914901 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 631658 Cm7 Cardiac mass QTL 7 5.32 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 1 196248093 241248093 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 2293700 Bmd27 Bone mineral density QTL 27 6.6 0.0001 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 1 224054293 243747962 Rat 2293701 Bmd34 Bone mineral density QTL 34 8.3 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 1 224054293 243747962 Rat 7387289 Uae45 Urinary albumin excretion QTL 45 2.86 0.0021 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 223262787 260522016 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 3 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 197670404 242670404 Rat 1581544 Rf52 Renal function QTL 52 0.05 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 1 232156370 259647894 Rat 1600363 Hc6 Hypercalciuria QTL 6 2.7 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 203995416 244113296 Rat 631536 Lnnr2 Liver neoplastic nodule remodeling QTL 2 2.9 0.0005 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705) 1 233948574 260522016 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 2302040 Pia35 Pristane induced arthritis QTL 35 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 216255568 260522016 Rat 631669 Iddm9 Insulin dependent diabetes mellitus QTL 9 2.8 0.039 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 1 233190394 258625266 Rat 7394701 Uae46 Urinary albumin excretion QTL 46 3.6 0.0056 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 201554356 246554356 Rat 1598821 Rf55 Renal function QTL 55 6.3 renal blood flow trait (VT:2000006) ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239) 1 218748008 257976495 Rat
RH128175
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 239,375,731 - 239,375,948 (+) MAPPER mRatBN7.2 Rnor_6.0 1 259,641,748 - 259,641,964 NCBI Rnor6.0 Rnor_6.0 1 259,057,482 - 259,057,698 NCBI Rnor6.0 Rnor_5.0 1 266,505,568 - 266,505,784 UniSTS Rnor5.0 Rnor_5.0 1 267,085,467 - 267,085,683 UniSTS Rnor5.0 RGSC_v3.4 1 245,686,048 - 245,686,264 UniSTS RGSC3.4 Celera 1 235,221,155 - 235,221,371 UniSTS Cytogenetic Map 1 q54 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
2
2
5
1
2
1
7
3
5
2
4
2
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000020940 ⟹ ENSRNOP00000020940
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 1 259,057,413 - 259,089,632 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000091116 ⟹ ENSRNOP00000074318
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 1 259,641,676 - 259,674,425 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000091297 ⟹ ENSRNOP00000071408
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 1 259,057,402 - 259,089,642 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000120003 ⟹ ENSRNOP00000089847
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 239,375,669 - 239,407,890 (-) Ensembl
RefSeq Acc Id:
NM_001108524 ⟹ NP_001101994
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 249,325,082 - 249,357,383 (-) NCBI mRatBN7.2 1 239,375,657 - 239,407,956 (-) NCBI Rnor_6.0 1 259,641,679 - 259,674,426 (-) NCBI Rnor_5.0 1 267,085,392 - 267,117,725 (-) NCBI RGSC_v3.4 1 245,685,979 - 245,718,198 (-) RGD Celera 1 235,221,086 - 235,253,280 (-) RGD
Sequence:
AGAAAAGGCGGAGGAGAGGGCGGCTGCCGGGGAGAGCGGGCCAGGGCTGGGGTCGGCGGCCAGCAGTTACCCCTGACCATCAACACATATGCACAAAGGATTTGGACTATATCCACCAGTCTTAGCAG AACAGGTGTTTGGATTTGTGACCACATCTCAACATGTTGAGACATGTGCAACGCTCCGGGCTCCAGCCCTTCAGCCAACGTCTGCTACCGTGGGTCCAGTCCATAGCTCTGCCCAGATCTCATCGCGT CCAGCCTTCAGCTATTAGACATGTTCGTTCCTGGAGCAACATCCCCTTTATCACGGTACCCCTCAGTCGTGCTCATGGCAAGCCCTTTGCCCACCGAAGCGAGCTGAAGCACGCCAAGAGAATTGTAG TGAAACTCGGCAGTGCCGTGGTGACCAGAGGAGATGAGTGTGGCCTGGCACTGGGGCGCCTGGCGTCTATTGTCGAACAGGTCTCGGTGCTGCAGAATCAGGGCCGAGAGATGATGCTGGTGACCAGT GGAGCGGTCGCCTTCGGCAAGCAGCGCCTGCGCCACGAGATCCTTCTGTCTCAGAGCGTGCGGCAAGCCCTGCACTCAGGACAGAACCATCTGAAGGAGATGGCAATTCCAGTCTTAGAGGCCCGAGC CTGCGCAGCCGCTGGACAGAGTGGGCTGATGGCCTTGTACGAGGCCATGTTTACACAGTACAGCATCTGTGCTGCCCAGATTTTGGTGACCAACCTGGATTTCCACGACGAGCAGAAGCGCAGAAATC TCAACGGCACACTACACGAGCTGCTTCGGATGAACATCGTCCCCATTGTCAACACCAACGACGCCGTTGTCCCCCCAGCTGAGCCCAACAGTGATCTTCAGGGGGTAAATGTGATTAGCGTTAAGGAC AACGATAGCCTAGCTGCCCGTCTGGCCGTGGAGATGAAAACTGACCTCCTGATTGTCCTCTCAGATGTGGAAGGCCTCTTTGACAGCCCCCCAGGCTCAGATGATGCAAAACTCATTGATATATTCTA CCCGGGAGATCAGCAGTCTGTGACATTTGGAACCAAGTCTAGAGTGGGCCTAGGGGGCATGGAAGCCAAGGTGAAAGCCGCCCTCTGGGCTTTGCAAGGTGGCACTTCTGTCGTCATTGCCAACGGAA CCCACCCCAAGGTGTCTGGGCACGTCATCACAGACATCGTGGAGGGAAAGAAAGTTGGCACCTTCTTTTCAGAAGTAAAGCCTGCTGGCCCTACGGTGGAGCAGCAGGGGGAGATGGCTCGGTCTGGA GGGAGAATGCTGGCCACCTTAGAGCCTGAACAGAGAGCTGAAATTATCAATCATCTGGCTGACCTGCTGACGGACCAGCGGGAAGAGATCCTGTTAGCCAACAAAAAAGACTTGGAGGAAGCAGAGGG AAGACTTGCAGGCCCCCTGCTGAAGCGTCTCAGCCTCTCCACGTCTAAACTGAACAGCCTGGCCATCGGGCTGCGGCAGATCGCAGCCTCCTCTCAGGAGAGCGTAGGCCGTGTCCTGCGCCGGACTC GGATTGCCAAAAACCTGGAGTTAGAACAAGTGACTGTCCCAATAGGTGTTTTACTGGTGATCTTTGAGTCTCGTCCTGACTGTCTACCCCAGGTGGCAGCCTTGGCCATTGCGAGTGGCAACGGCTTG TTGCTCAAAGGCGGGAAGGAGGCTATGCACAGCAACCGCATTCTTCACCTCCTGACCCAGGAGGCCCTCTCCATCCATGGAGTCAAGGAGGCCATACAGCTGGTAAACACCAGAGAAGAAGTGGAGGA TCTCTGCCGCCTGGACAAAATAATTGACCTGATCATCCCTCGAGGCTCCTCCCAGCTGGTCAGAGACATCCAGAAAGCTGCCAAGGGGATCCCAGTGATGGGCCACAGCGAAGGGATCTGCCACATGT ACGTGGATTCTGAAGCCAGTGTGGACAAGGTCACCCGACTTGTCAGAGACTCCAAATGTGAGTACCCAGCTGCCTGTAACGCCCTGGAGACTTTGCTCATCCACCGAGATCTGCTGAGAACACCCTTA TTTGACCAGATCATTGACATGCTCAGAGTGGAACAGGTAAAAATTCACGCAGGCCCCAAGTTTGCCTCCTACCTGACCTTCAGCCCCTCAGAAGTGAAGTCACTCCGGACAGAGTACGGGGACCTGGA AGTGTGCATCGAAGTGGTGGACAGCGTCCAGGAAGCCATTGATCACATCCATAAGTACGGCAGCTCCCACACAGATGTCATCGTCACCGAGAACGAGAAAACAGCCGAGTTCTTCCTCCAGCATGTGG ACAGTGCCTGCGTGTTCTGGAACGCCAGTACCCGCTTCTCTGATGGCTACCGATTTGGACTGGGAGCTGAAGTAGGAATCAGTACATCACGAATCCATGCCCGGGGACCAGTAGGACTCGAGGGATTG CTAACTACTAAGTGGTTGCTTCGAGGGCAAGACCACGTGGTCTCAGACTTCTCAGAGCACGGAAGGCTAAAGTATCTTCACGAGAACCTCCCTGTTCCCCAGAGGCATTTCAGCTGAGAGGAGCCAGT CAGTCAGGACTGTTCCGTGCAGTCTGGCACATGTAGGCCACTCGAGGATCTCCAGAGAGAACCTGATCTCATCCCCCACTTCTTGGAAGGGTCCGCCTTCTGGACAGTTCACCTATGCTTCTGGCTCA ACTCAGCCTGTCCAACCTTAGCTAATGTTCACACTCCATTCCGGCCTCCTTGTGTGTGTCTGTCTCTGTTACTGGGGCTGAATCTGGGGCCTGGCACATGCTAGGCAAATGATCCACCGTCACACGTC TCCCTGGCTCTGCAGTCCAGTCTCAGGAAGAGAATCATTGTCAGAGGCGGAGGCTTGGCTTTTCCCAGTCTGTTCACACCACAGGTAGAGACTAAGGGACGCATCTAACATCAGAGACAATGGGAAGT CCTGTCTGCCGTGACACCTCAGTGAGGGAGTCTCTGGGCGTTTGACTGGGCCAGCCTTGCTGGTCCTCAGCCTCTCGACATGGAATTCCATCTCTTTTATGTCTGCTCATCCTCAGAAGGGGAGACTG GGAATTCTTAAGGAAGGGTAACTCCTTAAAACCTTTAACATTTTCATTGGAAATGGAGACTAAAACAGACCGACCTACATCCACGGGGAGATGACCTTTGTGGCTGTGAAGTTATGGGTGTACATCTT CTACATCTACAGTCTGTCCCTGGCCTGGGGACACAGGGTACCTTCAAGGTAATTGGAATCTGAGCATCACGCTGGAGGGATGAATTTCAGGATGTCCCTACAAGTGGGAGGAAGATGGGCAATTATTG CTTGACCTTTTTACGTGAATTATTTTGTCATCCTATTCTTGACCTCCTGGACAAAGACTAGAGATTATTTTAATACTTTAGATTCTTTCCCCATTTTTTGAGAAATAAAGTTCTTACAAAAGTCCA
hide sequence
RefSeq Acc Id:
NM_001395675 ⟹ NP_001382604
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 249,325,082 - 249,357,383 (-) NCBI mRatBN7.2 1 239,375,657 - 239,407,956 (-) NCBI
RefSeq Acc Id:
NP_001101994 ⟸ NM_001108524
- Peptide Label:
isoform 1
- UniProtKB:
A6JH60 (UniProtKB/TrEMBL), A0A8I6AAN3 (UniProtKB/TrEMBL)
- Sequence:
MLRHVQRSGLQPFSQRLLPWVQSIALPRSHRVQPSAIRHVRSWSNIPFITVPLSRAHGKPFAHRSELKHAKRIVVKLGSAVVTRGDECGLALGRLASIVEQVSVLQNQGREMMLVTSGAVAFGKQRLR HEILLSQSVRQALHSGQNHLKEMAIPVLEARACAAAGQSGLMALYEAMFTQYSICAAQILVTNLDFHDEQKRRNLNGTLHELLRMNIVPIVNTNDAVVPPAEPNSDLQGVNVISVKDNDSLAARLAVE MKTDLLIVLSDVEGLFDSPPGSDDAKLIDIFYPGDQQSVTFGTKSRVGLGGMEAKVKAALWALQGGTSVVIANGTHPKVSGHVITDIVEGKKVGTFFSEVKPAGPTVEQQGEMARSGGRMLATLEPEQ RAEIINHLADLLTDQREEILLANKKDLEEAEGRLAGPLLKRLSLSTSKLNSLAIGLRQIAASSQESVGRVLRRTRIAKNLELEQVTVPIGVLLVIFESRPDCLPQVAALAIASGNGLLLKGGKEAMHS NRILHLLTQEALSIHGVKEAIQLVNTREEVEDLCRLDKIIDLIIPRGSSQLVRDIQKAAKGIPVMGHSEGICHMYVDSEASVDKVTRLVRDSKCEYPAACNALETLLIHRDLLRTPLFDQIIDMLRVE QVKIHAGPKFASYLTFSPSEVKSLRTEYGDLEVCIEVVDSVQEAIDHIHKYGSSHTDVIVTENEKTAEFFLQHVDSACVFWNASTRFSDGYRFGLGAEVGISTSRIHARGPVGLEGLLTTKWLLRGQD HVVSDFSEHGRLKYLHENLPVPQRHFS
hide sequence
Ensembl Acc Id:
ENSRNOP00000074318 ⟸ ENSRNOT00000091116
Ensembl Acc Id:
ENSRNOP00000020940 ⟸ ENSRNOT00000020940
Ensembl Acc Id:
ENSRNOP00000071408 ⟸ ENSRNOT00000091297
Ensembl Acc Id:
ENSRNOP00000089847 ⟸ ENSRNOT00000120003
RefSeq Acc Id:
NP_001382604 ⟸ NM_001395675
- Peptide Label:
isoform 2
- UniProtKB:
A0A8I6AAN3 (UniProtKB/TrEMBL)
RGD ID: 13690899
Promoter ID: EPDNEW_R1422
Type: initiation region
Name: Aldh18a1_1
Description: aldehyde dehydrogenase 18 family, member A1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 259,674,435 - 259,674,495 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
LOC108348083
delta-1-pyrroline-5-carboxylate synthase
Data merged from RGD:11512751
737654
PROVISIONAL
2016-08-02
LOC108348083
delta-1-pyrroline-5-carboxylate synthase
Symbol and Name status set to provisional
70820
PROVISIONAL
2010-04-23
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
Pycs
pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Pycs
pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase)
Pycs_predicted
pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase) (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Pycs_predicted
pyrroline-5-carboxylate synthetase (glutamate gamma-semialdehyde synthetase) (predicted)
Symbol and Name status set to approved
70820
APPROVED